Related Experiment Video

Updated: Jul 20, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

399

MicroRNA targeting: A novel therapeutic intervention for ovarian cancer

Elmira Roshani Asl1, Sajed Sarabandi2, Behrouz Shademan3

  • 1Social Determinants of Health Research Center, Saveh University of Medical Sciences, Saveh, Iran.

Biochemistry and Biophysics Reports
|July 31, 2023
PubMed

Insights

This study explores microRNAs (miRNAs) as key players in ovarian cancer. Targeting these molecules offers promising diagnostic and therapeutic strategies for this complex disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer involves complex cellular communication networks driving disease progression.
  • Identifying molecular abnormalities is crucial for improving diagnostics and therapeutics.
  • MicroRNAs (miRNAs) are implicated in various cellular processes and disease states.

Purpose of the Study:

  • To identify critical molecular abnormalities in ovarian cancer.
  • To investigate the role of microRNAs (miRNAs) as diagnostic biomarkers.
  • To explore the therapeutic potential of miRNA-based interventions in ovarian cancer.

Main Methods:

  • Literature review focusing on miRNA research in ovarian cancer.
  • Analysis of studies investigating miRNA expression profiles in ovarian cancer patients.
  • Examination of preclinical and clinical data on miRNA-targeted therapies.

Main Results:

  • MicroRNAs (miRNAs) are significantly dysregulated in ovarian cancer.
  • Specific miRNAs show potential as sensitive and specific diagnostic biomarkers.
  • Targeting miRNAs can modulate multiple oncogenic pathways, offering therapeutic benefits.

Conclusions:

  • MicroRNA (miRNA)-based approaches represent a promising frontier for ovarian cancer diagnosis and treatment.
  • Further research into specific miRNA roles and targeted delivery systems is warranted.
  • Understanding miRNA involvement in ovarian cancer pathogenesis can lead to novel clinical strategies.
Keywords:
BiomarkerDiagnostic biomarkerOvarian cancerPrognosticsTherapeutic strategymicroRNA

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.7K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.4K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K